Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding Yan Xu, MD, Sam Schulman, MD, PhD, Dar Dowlatshahi, MD, PhD, Anne M. Holbrook, MD, Christopher S. Simpson, MD, Lois E. Shepherd, MD, Philip S. Wells, MD, Antonio Giulivi, MD, Tara Gomes, MHSc, Muhammad Mamdani, PharmD, MPH, Wayne Khuu, MPH, Eliot Frymire, MA, Ana P. Johnson, PhD CHEST Volume 152, Issue 1, Pages 81-91 (July 2017) DOI: 10.1016/j.chest.2017.02.009 Copyright © 2017 The Authors Terms and Conditions
Figure 1 Flow diagram of participants. CHEST 2017 152, 81-91DOI: (10.1016/j.chest.2017.02.009) Copyright © 2017 The Authors Terms and Conditions
Figure 2 Kaplan-Meier curve of 30-day mortality following major bleeding event from day of presentation. aRR, adjusted relative risk; DOAC = direct oral anticoagulant. CHEST 2017 152, 81-91DOI: (10.1016/j.chest.2017.02.009) Copyright © 2017 The Authors Terms and Conditions